Standardizing Scale-up: Insights into Producing Clinical and Commercial RNA-LNP Drug Products

Standardizing Scale-up: Insights into Producing Clinical and Commercial RNA-LNP Drug Products

Standardizing scale-up: Insights into producing clinical and commercial RNA-LNP drug productsПодробнее

Standardizing scale-up: Insights into producing clinical and commercial RNA-LNP drug products

Session 2: mRNA LNP scale up for GMP Vaccine Production - Dr. Jason ColemanПодробнее

Session 2: mRNA LNP scale up for GMP Vaccine Production - Dr. Jason Coleman

Developing Scalable RNA-LNP Drug Products for Clinical ReadinessПодробнее

Developing Scalable RNA-LNP Drug Products for Clinical Readiness

Process & Analytical Insights for GMP Manufacturing of mRNA-Lipid NanoparticlesПодробнее

Process & Analytical Insights for GMP Manufacturing of mRNA-Lipid Nanoparticles

Session 1: Translation of RNA Nanomedicines from Design to Clinical - Dr. Heinrich HaasПодробнее

Session 1: Translation of RNA Nanomedicines from Design to Clinical - Dr. Heinrich Haas

Scale Up and Manufacturing of RNA-LNPs for a COVID-19 VaccineПодробнее

Scale Up and Manufacturing of RNA-LNPs for a COVID-19 Vaccine

RNA-LNP Therapeutics Panel DiscussionПодробнее

RNA-LNP Therapeutics Panel Discussion

Scale-up and Manufacturing of Self-amplifying RNA-LNPs for a COVID-19 VaccineПодробнее

Scale-up and Manufacturing of Self-amplifying RNA-LNPs for a COVID-19 Vaccine

Clinical and Commercial Manufacturing of mRNA Therapeutics: Opportunities and ChallengesПодробнее

Clinical and Commercial Manufacturing of mRNA Therapeutics: Opportunities and Challenges

New Approaches for LNP Design and Microfluidic Manufacturing for Vaccines and CAR T Cell TherapyПодробнее

New Approaches for LNP Design and Microfluidic Manufacturing for Vaccines and CAR T Cell Therapy

Manufacture of LNPs for RNA deliveryПодробнее

Manufacture of LNPs for RNA delivery

RNA-Lipid Nanoparticle Platform for the Multi-step engineering of gene edited CAR-T cells.Подробнее

RNA-Lipid Nanoparticle Platform for the Multi-step engineering of gene edited CAR-T cells.

CMC Considerations for Developing an Effective mRNA/LNP TherapeuticПодробнее

CMC Considerations for Developing an Effective mRNA/LNP Therapeutic

Overcoming Key Challenges in Vaccine DevelopmentПодробнее

Overcoming Key Challenges in Vaccine Development

Solvent-free production methods for liposomes and lipid nanoparticlesПодробнее

Solvent-free production methods for liposomes and lipid nanoparticles

Accelerate development by outsourcing MRNA–LNP formulations to a CDMOПодробнее

Accelerate development by outsourcing MRNA–LNP formulations to a CDMO

Optimized and Scalable LNP Composition for RNA Vaccine DeliveryПодробнее

Optimized and Scalable LNP Composition for RNA Vaccine Delivery

Manufacturing RNA lipid nanoparticles to deliver high quality transformative medicinesПодробнее

Manufacturing RNA lipid nanoparticles to deliver high quality transformative medicines